Linear Synthesis of Gram-Positive Bacteriocins via Solid Phase Peptide Assembly
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The synthesis of gram-positive class II bacteriocins, such as pediocin PA-1 and bactofencin A, is challenging due to their structural complexity and low yields, limiting their commercial exploitation and effectiveness against pathogens like Listeria monocytogenes, which poses significant health and economic risks in food safety.
Innovation Solution
A process for the linear synthesis of gram-positive class II bacteriocins using solid phase peptide synthesis, including stepwise addition of amino acids, pseudoproline positioning, and in situ disulfide bond formation, enhances yield and purity, allowing for the production of pediocin PA-1 and bactofencin A variants with improved antimicrobial activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional synthesis methods are used for gram-positive class II bacteriocins, then the structural complexity is maintained, but the yield remains low and purification is lengthy
Solution Approach 1:
The bacteriocin synthesis process is divided into modular stages: solid-phase peptide synthesis for linear chain assembly, followed by controlled disulfide bond formation. This segmentation allows each step to be optimized independently, improving overall yield while managing structural complexity systematically
Solution Approach 2:
The linear peptide chain is synthesized completely before introducing disulfide bonds. This preliminary action allows the backbone structure to be established first, simplifying the subsequent folding and disulfide formation steps, thereby improving yield and reducing purification complexity
2Ease of manufacture
If purified bacteriocins are isolated from fermentation batches, then natural production is achieved, but the cost remains high due to lengthy purification processes
Solution Approach 1:
The patent replaces complex mechanical purification processes with a streamlined approach: solid-phase synthesis produces highly pure linear peptides that require minimal purification, and disulfide bonds form in situ under controlled conditions, eliminating the need for extensive purification steps and reducing production costs
Solution Approach 2:
The synthesis method changes the physical and chemical parameters of the production process by using solid-phase synthesis conditions that inherently produce high-purity products, and by controlling the oxidation environment to enable spontaneous disulfide formation, thereby simplifying purification and reducing costs
3Reliability
If chemical preservatives are used, then preservation effectiveness is achieved, but health risks and consumer concerns increase
Solution Approach 1:
The patent employs bacteriocins as single-use, naturally degradable antimicrobial agents that provide effective preservation without persistent health risks. These peptides exert their antimicrobial effect and then degrade naturally, unlike synthetic preservatives that may accumulate and pose long-term health concerns
Solution Approach 2:
Bacteriocins are naturally produced by bacteria as their own defense mechanism. By harnessing this natural antimicrobial property, the system provides self-service preservation without requiring external chemical additives, thereby maintaining effectiveness while eliminating synthetic preservative risks
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method achieves high yields and purity of bacteriocins, demonstrating strong antimicrobial activity against Listeria monocytogenes and other pathogens, offering a promising solution for food safety and reducing the risk of antibiotic resistance.
Implementation Method 1
stepwise addition of selected amino acids to a solid support
Implementation Method 2
oxidation of the linear bacteriocin to form a disulfide bond
Data Source
AI summary
A process for the linear synthesis of a gram-positive class II bacteriocin or a variant thereof is disclosed herein. The process comprises the stepwise addition of selected amino acids to a solid support; pseudoproline positioning and reopening; and cleavage of the gram-positive class II bacteriocin or the variant thereof from the solid support to provide a linear gram-positive class II bacteriocin or variant thereof; and in situ disulfide bond formation. Various applications and uses of the synthetic bacteriocins are also disclosed. The synthetic process can also be used to synthesize variants of bacteriocins by the selective substitution of one or more amino acids and/or additions and/or deletions of selected amino acids.